An increase of one standard deviation in (SHBG) is associated with a 2.42-fold increased risk of pathological fracture with osteoporosis.
Higher levels of SHBG may significantly elevate the risk of pathological fractures in individuals with osteoporosis.
A genetically predetermined increase of one standard deviation in is linked to a 37% reduction in the risk of foot fractures.
The same increase in bioavailable testosterone is associated with a 39% decrease in the risk of forearm fractures.
Elevated SHBG levels are shown to have a major causal effect on specific fracture risks, while bioavailable testosterone may help prevent certain fractures.
No significant causal effects of bioavailable testosterone or SHBG levels were observed for most fractures in the general population.
Simplified
OBJECTIVE: Prior observational studies have reported that levels of sex hormones constitute a risk factor for the fracture. The aim of this study was to ascertain whether there is a causal relationship between the levels of sex hormones and the risk of fracture through (MR).
METHODS: Single-nucleotide polymorphisms (SNPs) associated with two indicators of sex hormone levels, circulating (SHBG) and levels, as exposures were selected from a large genome-wide association study (GWAS) from UK Biobank. The summary statistics for 11 different types of fracture as outcomes from the FinnGen consortium. This study employed the two-sample MR approach. For the main analysis, the inverse-variance-weighted (IVW) method was utilized. To assess the heterogeneity of MR results, the IVW method and MR-Egger method were utilized. To evaluate potential pleiotropy, MR-Egger regression was conducted. Additionally, a leave-one-SNP-out test was performed to assess the robustness of MR results to the exclusion of any individual SNP.
RESULTS: The MR analyses demonstrated a conspicuous impact of SHBG on the risk of pathological fracture with osteoporosis (OP). We found that an increase of one standard deviation (SD) in SHBG correspondingly increased the risk of pathological fracture with OP [odds ratio (OR) 2.42, 95% confidence interval (CI), 1.52-3.85; p = 1.93 × 10]. The bioavailable testosterone showed the negative casual genetic associations with fractures of foot and forearm. An increase of one SD in the genetically predetermined bioavailable testosterone was associated with a reduction of 37% in the risk of fracture of foot (OR 0.63, 95% Cl 0.49 to 0.81; p = 3.37 × 10), as well as a 39% decrease in the risk of fracture of forearm (OR 0.61, 95% Cl 0.50 to 0.76; p = 5.40 × 10). -4 -4 -6
CONCLUSIONS: Our study confirms that individuals experiencing elevated SHBG concentrations showed a major causal effect on pathological fracture with OP. High bioavailable testosterone levels play an important role in preventing the fractures of foot and forearm. Although increasing bioavailable testosterone and decreasing SHBG levels had no casual effect on most fractures in the general population, they are likely to have the most clinically relevant effect on certain fracture risk reduction.
Key numbers
2.42
Increase in Risk of Pathological Fracture with Elevated
Odds ratio for pathological fracture with osteoporosis per SD increase in
37%
Decrease in Risk of Foot Fracture with Higher
Percentage reduction in risk of foot fracture per SD increase in
39%
Decrease in Risk of Forearm Fracture with Higher
Percentage reduction in risk of forearm fracture per SD increase in
Full Text
We can’t show the full text here under this license.
